TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Evolan Pharma AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 66,220 | 65,385 | 54,138 |
Financial expenses | 158 | 132 | 355 |
Earnings before taxes | 21,017 | 19,061 | 12,157 |
EBITDA | 27,554 | 25,915 | 18,957 |
Total assets | 77,592 | 54,003 | 41,901 |
Current assets | 44,226 | 34,599 | 24,895 |
Current liabilities | 19,208 | 14,967 | 14,987 |
Equity capital | 47,401 | 35,762 | 22,640 |
- share capital | 9 | 10 | 10 |
Employees (average) | 27 | 27 | 27 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 61.1% | 66.2% | 54.0% |
Turnover per employee | 2,453 | 2,422 | 2,005 |
Profit as a percentage of turnover | 31.7% | 29.2% | 22.5% |
Return on assets (ROA) | 27.3% | 35.5% | 29.9% |
Current ratio | 230.2% | 231.2% | 166.1% |
Return on equity (ROE) | 44.3% | 53.3% | 53.7% |
Change turnover | 6,132 | 12,249 | 10,260 |
Change turnover % | 10% | 23% | 23% |
Chg. No. of employees | 0 | 0 | 1 |
Chg. No. of employees % | 0% | 0% | 4% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.